6-OHDA generated ROS induces DNA damage and p53-and PUMA-dependent cell death

被引:66
作者
Bernstein, Alison I. [1 ]
Garrison, Sean P. [2 ]
Zambetti, Gerard P. [2 ]
O'Malley, Karen L. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA
[2] St Jude Childrens Hosp, Dept Biochem, Memphis, TN 38105 USA
来源
MOLECULAR NEURODEGENERATION | 2011年 / 6卷
基金
美国国家卫生研究院;
关键词
UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ACTIVATING TRANSCRIPTION FACTOR-3; PARKINSONS-DISEASE; DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; OXIDATIVE STRESS; SYMPATHETIC NEURONS; DISTINCT MECHANISMS; HYDROGEN-PEROXIDE;
D O I
10.1186/1750-1326-6-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Parkinson's disease (PD) is characterized by the selective loss of dopaminergic neurons in the substantia nigra (SN), resulting in tremor, rigidity, and bradykinesia. Although the etiology is unknown, insight into the disease process comes from the dopamine (DA) derivative, 6-hydroxydopamine (6-OHDA), which produces PD-like symptoms. Studies show that 6-OHDA activates stress pathways, such as the unfolded protein response (UPR), triggers mitochondrial release of cytochrome-c, and activates caspases, such as caspase-3. Because the BH3-only protein, Puma (p53-upregulated mediator of apoptosis), is activated in response to UPR, it is thought to be a link between cell stress and apoptosis. Results: To test the hypothesis that Puma serves such a role in 6-OHDA-mediated cell death, we compared the response of dopaminergic neurons from wild-type and Puma-null mice to 6-OHDA. Results indicate that Puma is required for 6-OHDA-induced cell death, in primary dissociated midbrain cultures as well as in vivo. In these cultures, 6-OHDA-induced DNA damage and p53 were required for 6-OHDA-induced cell death. In contrast, while 6-OHDA led to upregulation of UPR markers, loss of ATF3 did not protect against 6-OHDA. Conclusions: Together, our results indicate that 6-OHDA-induced upregulation of Puma and cell death are independent of UPR. Instead, p53 and DNA damage repair pathways mediate 6-OHDA-induced toxicity.
引用
收藏
页数:13
相关论文
共 54 条
  • [1] DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
    Bakkenist, CJ
    Kastan, MB
    [J]. NATURE, 2003, 421 (6922) : 499 - 506
  • [2] A COMPARISON OF MODEL-BASED (2D) AND DESIGN-BASED (3D) STEREOLOGICAL METHODS FOR ESTIMATING CELL NUMBER IN THE SUBSTANTIA NIGRA PARS COMPACTA (SNpc) OF THE C57BL/6J MOUSE
    Baquet, Z. C.
    Williams, D.
    Brody, J.
    Smeyne, R. J.
    [J]. NEUROSCIENCE, 2009, 161 (04) : 1082 - 1090
  • [3] Cytosine arabinoside rapidly activates Bax-dependent apoptosis and a delayed Bax-independent death pathway in sympathetic neurons
    Besirli, CG
    Deckwerth, TL
    Crowder, RJ
    Freeman, RS
    Johnson, EM
    [J]. CELL DEATH AND DIFFERENTIATION, 2003, 10 (09) : 1045 - 1058
  • [4] Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease
    Biswas, SC
    Ryu, E
    Park, C
    Malagelada, C
    Greene, LA
    [J]. NEUROCHEMICAL RESEARCH, 2005, 30 (6-7) : 839 - 845
  • [5] Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease
    Blum, D
    Torch, S
    Lambeng, N
    Nissou, MF
    Benabid, AL
    Sadoul, R
    Verna, JM
    [J]. PROGRESS IN NEUROBIOLOGY, 2001, 65 (02) : 135 - 172
  • [6] Extracellular toxicity of 6-hydroxydopamine on PC12 cells
    Blum, D
    Torch, S
    Nissou, MF
    Benabid, AL
    Verna, JM
    [J]. NEUROSCIENCE LETTERS, 2000, 283 (03) : 193 - 196
  • [7] INCREASED POLY(ADP-RIBOSYL)ATION IN INTACT-CELLS BY CISPLATIN TREATMENT
    BURKLE, A
    CHEN, G
    KUPPER, JH
    GRUBE, K
    ZELLER, WJ
    [J]. CARCINOGENESIS, 1993, 14 (04) : 559 - 561
  • [8] VITAMIN-E ATTENUATES THE TOXIC EFFECTS OF INTRASTRIATAL INJECTION OF 6-HYDROXYDOPAMINE (6-OHDA) IN RATS - BEHAVIORAL AND BIOCHEMICAL-EVIDENCE
    CADET, JL
    KATZ, M
    JACKSONLEWIS, V
    FAHN, S
    [J]. BRAIN RESEARCH, 1989, 476 (01) : 10 - 15
  • [9] Choi WS, 1999, J NEUROSCI RES, V57, P86, DOI 10.1002/(SICI)1097-4547(19990701)57:1<86::AID-JNR9>3.0.CO
  • [10] 2-E